Oxford Medical Simulation secures £2.1m from ACF Investors and Nicolaus Henke to fund expansion
The investment round was supported by ACF Investors and Nicolaus Henke to fuel US growth and product development.
Oxford Medical Simulation develops virtual reality platforms for clinical education and training. The company provides immersive scenarios designed to improve healthcare preparedness and patient safety.
Oxford Medical Simulation has secured £2.1m in fresh funding from backers including ACF Investors and angel investor Nicolaus Henke. The capital will be deployed to broaden the company product range and accelerate expansion across the United States. The platform currently enables healthcare institutions to scale training capacity significantly beyond traditional centre limits.
From the founder
"We see this funding as an opportunity to supercharge our growth and rapidly increase the number of healthcare professionals around the world who have access to our training."
Michael Wallace
co-founder and CEO at Oxford Medical Simulation
Investor perspective
"Oxford Medical Simulation is providing state of the art, immersive training which uses emerging VR and AR technology to tackle the global healthcare worker shortage head-on. The team has already achieved some fantastic results – as seen in the company’s growth momentum and the quality of its customer base. It is, quite rightly, a demanding customer base, but they have shown the potential to ensure we all have access to highly trained healthcare professionals in the future."
Tim Mills
Managing Partner, ACF Investors
Use of funds
- 01Continue product development
- 02Expand into international markets
Investors
Categories
About the company
Oxford Medical Simulation
Oxford Medical Simulation builds virtual reality platforms for healthcare training.